IP Library Granted Patent US 12,098,153
Granted Patent B2
US 12,098,153 · App. 18/376,525 · Granted Sep 24, 2024

Small molecule inhibitors targeting

Inventors: Yu Chen (Tampa, FL); Michael Sacco (Tampa, FL); James Leahy (Tampa, FL); Elena Bray (Tampa, FL); Xingmin Sun (Tampa, FL); Xiujun Zhang (Tampa, FL)
Assignee: University of South Florida
C07D471/08A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,098,153
App. No.
18/376,525
Granted
Sep 24, 2024
Kind
B2
Abstract

Disclosed herein are compounds that can prevent and treat C. difficile by inhibiting sporulation. Also disclosed herein are compositions and formulations comprising the compound disclosed herein. Methods of preventing and treating C. difficile comprising administering the compounds described herein are also disclosed.

Claims (16)

1. A compound represented by the formula:

2. The compound of claim 1 , wherein the compound is represented by the formula:

3. The compound of claim 1 , wherein the compound is represented by:

4. The compound of claim 1 , wherein the compound is represented by:

5. The compound of claim 1 , wherein the compound is represented by:

6. A pharmaceutical composition, comprising the compound of claim 1 and an antibiotic.

7. A formulation, comprising the compound of claim 1 and a pharmaceutically acceptable excipient.

8. A method of preventing and treating C. difficile , infection comprising administering to a patient in need thereof a therapeutically effective amount of the compound of claim 1 .

9. A compound represented by the formula:

10. The compound of claim 9 , wherein the compound is represented by:

11. The compound of claim 9 , wherein the compound is represented by:

12. The compound of claim 9 , wherein the compound is represented by:

13. The compound of claim 9 , wherein the compound is represented by:

14. A pharmaceutical composition, comprising the compound of claim 9 and an antibiotic.

15. A formulation, comprising the compound of claim 9 and a pharmaceutically acceptable excipient.

16. A method of preventing and treating C. difficile , infection comprising administering to a patient in need thereof a therapeutically effective amount of the compound of claim 9 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2024
From: CHEN, YU; SACCO, MICHAEL; LEAHY, JAMES; BRAY, ELENA; SUN, XINGMIN; ZHANG, XIUJUN
To: UNIVERSITY OF SOUTH FLORIDA
Reel/Frame 068226/0025 →
CONFIRMATORY LICENSE Recorded Feb 1, 2024
From: UNIVERSITY OF SOUTH FLORIDA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 066407/0104 →
Continuity (3)
Continuation 17850650 · Jun 27, 2022
Provisional Application 63202834 · Jun 25, 2021
Related Publication 20240051959A1 · Feb 15, 2024